Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHT.L Regulatory News (GHT)

  • There is currently no data for GHT

Trading Update

4 Oct 2017 07:00

RNS Number : 6184S
Gresham Technologies PLC
04 October 2017
 

4 October 2017

Gresham Technologies plc

Two important CTC wins in North America in third quarter, trading in line

Gresham Technologies plc (LSE: "GHT", "Gresham" or the "Group"), the leading software and services company that specialises in providing real-time transaction control and enterprise data integrity solutions, is pleased to provide the following trading update.

During the third quarter of 2017, the Group signed two important new Clareti Transaction Control (CTC) clients in the US market, the first of which, a regulatory control deployment, was previously announced on 29 August 2017. The second win is with the US capital markets division of one of Asia's largest financial services firms who will use the technology to replace manual intensive data integrity checks and enable senior management to certify and be accountable for the quality of its trading related data. Other parts of the business continue to perform as planned.

Further, Gresham is pleased to confirm that there have been high levels of customer retention in the C24 Technologies business acquired on 10 October 2016, and accordingly the first deferred consideration payment is expected to be paid as planned in October 2017.

The Group is trading in line with Board expectations and management remains confident in the full year outlook.

 

Enquiries

Gresham Technologies plc

+44 (0) 207 653 0200

Ian Manocha

Rob Grubb

N+1 Singer (Joint Broker)

+44 (0) 207 496 3000

Shaun Dobson

Lauren Kettle

Cantor Fitzgerald Europe (Joint Broker)

+44 (0) 207 894 7000

Marc Milmo

Catherine Leftley

Callum Butterfield

 

Note to editors

Gresham's award-winning Clareti software platform has been designed to provide financial institutions with complete certainty in their data processing. Clareti is a highly flexible and fully scalable platform for assuring enterprise data integrity and is designed to address today's most challenging financial control, internal risk management, data governance and regulatory compliance problems. Gresham's portfolio of applications based on the Clareti platform, including Clareti Transaction Control (CTC), Clareti Accounts Receivable Management (Clareti ARM), Clareti Loan Control (CLC) and Clareti 24 Integration Objects (C24 IO), provide innovative industry specific solutions for real-time data management.

Gresham Technologies plc is a leading software and services company that specialises in providing real-time transaction control and enterprise data integrity solutions. Listed on the main market of the London Stock Exchange (GHT.L) and headquartered in the City of London, customers include some of the world's largest financial institutions, all of whom are served locally from offices located in Europe, North America and Asia Pacific.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBCBDGBUGBGRX
Date   Source Headline
26th Jul 20227:00 amRNSInterim Report Announcement
15th Jul 20227:00 amRNSInvestor Presentation
5th Jul 20227:00 amRNSTrading Update and Notice of Results
16th May 202211:09 amRNSHolding(s) in Company
10th May 20226:00 pmRNSResult of AGM
10th May 20227:00 amRNSAGM Statement
6th May 20227:00 amRNS£6.3m Clareti software contract with Tier 1 bank
1st Apr 20227:00 amRNSNotice of AGM and Dividend Timetable
30th Mar 20227:00 amRNSDirector Declaration
8th Mar 20227:00 amRNSFinal Results
25th Feb 20227:00 amRNSNotice of Results and Presentations
11th Jan 20227:00 amRNSTrading Update
25th Nov 20217:00 amRNSTrading Update and Strategic Contract Extension
22nd Oct 20219:14 amRNSConditional Share Awards and PDMR Dealings
24th Sep 20217:00 amRNSMajor Contract Extension with Key Account
8th Sep 20216:18 pmRNSHolding(s) in Company
29th Jul 20216:27 pmRNSExercise of Options
27th Jul 20212:50 pmRNSHolding(s) in Company
21st Jul 20217:00 amRNSInterim Report Announcement
14th Jul 20217:00 amRNSNotice of Results and Presentations
7th Jul 202111:25 amRNSHolding(s) in Company
6th Jul 20217:00 amRNSTrading Update
24th Jun 20213:30 pmRNSHolding(s) in Company
23rd Jun 20215:00 pmRNSHolding(s) in Company
23rd Jun 20211:10 pmRNSPDMR Shareholding
22nd Jun 20213:45 pmRNSHolding(s) in Company
21st Jun 20211:16 pmRNSResult of General Meeting
10th Jun 20217:00 amRNSGeneral Meeting Proceedings
3rd Jun 20219:31 amRNSHolding(s) in Company
2nd Jun 20215:02 pmRNSHolding(s) in Company
1st Jun 202111:59 amRNSPublication of Circular and Notice of GM
28th May 202111:54 amRNSResults of conditional Placing and Retail Offer
28th May 20217:01 amRNSPrimaryBid Offer
28th May 20217:00 amRNSProposed Acquisition, Placing and Retail Offer
10th May 20212:02 pmRNSResult of AGM
10th May 20217:00 amRNSAGM Statement
30th Apr 20217:00 amRNSAnnual General Meeting Proceedings
21st Apr 20212:56 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSDirector equity awards
1st Apr 20215:17 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSNotice of AGM and Dividend Timetable
24th Mar 20217:00 amRNSExercise of Options
22nd Mar 20217:00 amRNSClareti Contract Win
11th Mar 20217:00 amRNSClareti contract win
9th Mar 20217:00 amRNSFinal Results
2nd Mar 20217:00 amRNSNotice of Results and Presentations
26th Jan 202111:35 amRNSHolding(s) in Company
7th Jan 20217:00 amRNSHolding(s) in Company
6th Jan 20217:00 amRNSTrading Update
30th Dec 202012:31 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.